{"id":"W4386270891","doi":"10.1016/s2152-2650(23)00857-1","title":"POSTER: MM-163 Long-Term Follow-Up From MajesTEC-1 of Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Patients With Relapsed/ Refractory Multiple Myeloma (RRMM)","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Multiple myeloma; Antibody; Medicine; Refractory (planetary science); Bispecific antibody; Antigen; Cancer research; Virology; Immunology; Materials science; Monoclonal antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005899016,0.000298573,0.000951916,0.000299883,0.0007081095,0.0006025686,0.0003746358,0.0007325034,0.002447976],"category_scores_gemma":[0.0008190836,0.0001446911,0.001198719,0.0003222727,0.0002239404,0.0005435624,0.0003739975,0.001226227,0.0007605713],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000705914,"about_ca_system_score_gemma":0.0003955642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001781332,"about_ca_topic_score_gemma":0.002242186,"domain_scores_codex":[0.9996965,0.000048394,0.0000321528,0.00007074617,0.00004838144,0.0001038098],"domain_scores_gemma":[0.9995516,0.00007615377,0.00009489256,0.00003867947,0.00004617972,0.0001925174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1520952,0.003807974,0.5406404,0.0005096528,0.002336146,0.01375543,0.0006415717,0.001181831,0.0148458,0.0002572622,0.0128337,0.2570951],"study_design_scores_gemma":[0.004643152,0.03880406,0.9326739,0.0001637096,0.001726449,0.00661913,0.0001865007,0.0007783055,0.00306961,0.0002812174,0.0109863,0.00006768419],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9844534,0.007350438,0.0002871171,0.0009375224,0.0002654135,0.00009861089,0.001735913,0.00005100719,0.004820689],"genre_scores_gemma":[0.9935139,0.0009196658,0.0001278148,0.0007038882,0.0001684138,0.00004667086,0.002053283,0.000009922122,0.002456318],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002447976,"threshold_uncertainty_score":0.008189261,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03199682874755631,"score_gpt":0.3220475571111516,"score_spread":0.2900507283635953,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}